Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE: DBD)
52,900
Open53,000
High53,500
Low52,500
Vol24,600
Market Cap.3,959.22
Remain Bid2,800
Remain Ask8,400
52Wk High59,700
52Wk Low40,600
52Wk Avg Vol92,146
Foreign Buy200
Frgn Owned(%)13.28
Dividend
Dividend Yield-
Beta0.17
EPS3,563
P/E15.02
F P/E18.63
BVPS19,090
P/B2.80
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| Date | Close | Change | Volume |
|---|---|---|---|
| 04/16/2024 | 52,900 | -600 (-1.12%) | 24,600 |
| 04/15/2024 | 53,500 | -800 (-1.47%) | 32,200 |
| 04/12/2024 | 54,300 | 300 (+0.56%) | 68,900 |
| 04/11/2024 | 54,000 | -700 (-1.28%) | 21,700 |
| 04/10/2024 | 54,700 | -200 (-0.36%) | 28,800 |
| 03/22/2023 | DBD Dividend payment in cash with 20.00% for 2022 (Record date) |
| 03/22/2023 | DBD Dividend payment in cash with 20.00% for 2022 |
| 06/09/2022 | DBD Dividend payment by share with 30.00% for 2021 (Record date) |
| 06/14/2021 | DBD Dividend payment by share with 10.00% for 2020 (Record date) |
| 03/15/2021 | DBD Dividend payment in cash with 15.00% for 2020 (Record date) |
| 04/04/2024 | 2024 Annual Shareholders’Meeting Documents |
| 03/26/2024 | Explanation for Audited FS 2023 |
| 03/26/2024 | Audited Parent Company FS 2023 |
| 03/26/2024 | Audited Consolidated FS 2023 |
| 03/08/2024 | Corporate Governance Report 2023 |
Name: Binh Dinh Pharmaceutical and Medical Equipment JSC
Abbreviation:BIDIPHAR
Address: 498 Nguyen Thai Hoc Street, Quang Trung Ward Quy Nhon Binh Dinh
Telephone: (84.256) 384 6500
Fax: (84.256) 384 6846
Email:info@bidiphar.com
Website:https://www.bidiphar.com
Exchange: HOSE
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 06/15/2018
Chartered capital: 748,835,590,000
Listed shares: 74,883,559
Shares outstanding: 74,843,474
Status: Operating
Tax code: 4100259564
Establishment license: 264/QĐ-UB
Issued date: 06/23/2010
Business license: 3503000205
Issued date: 09/01/2010
Main business scope:
- Producing and trading pharmaceuticals, pharmaceutical materials, chemicals, medical equipment.
- Carrying out researches in healthcare industry.
- Providing services in the field of pharmaceutical production.
- Others under the business license.
- 05 May 1995: Binh Dinh Pharmaceutical and Medical Equipment Company was established through merging of Binh Dinh Pharmaceutical and Medical Materials Company and Binh Dinh Pharmaceutical Company under the Decision No.922/QD-UB issued by Binh Dinh Provincial People's Committee;
- 27 June 2006: Put into operation under the model of Parent Company-Subsidiary under the Decision No. 102/2006/QD-UBND issued by Binh Dinh Provincial People's Committee;
- 01 July 2010: Parent Company was transformed from State-Owned Enterprise into One-Member Limited Company under the Decision No.264/QD-UBND issued by Binh Dinh Provincial People's Committee;
- 27 March 2014: Put into operation under the model of a joint stock company with a charter capital of VND268,627,000,000 under the business registration certificate No.4100259564 amended for the first time by Binh Dinh Department of Planning and Investment;
- 25 November 2014: Became a public company;
- 25 October 2016: Charter capital was raised up to VND523,790,000,000;
- 16 January 2017: Traded on UPCOM market;
- 08 June 2018: Cancelled transaction registration on UPCOM market;
- 24 May 2018: Listed on Hochiminh Stock Exchange (HOSE);
- 15 June 2018: Traded on Hochiminh Stock Exchange (HOSE);
- 04/27/2024 DBD General Meeting of Shareholders for 2024
- 04/21/2023 DBD General Meeting of Shareholders for 2023
- 03/22/2023 DBD Dividend payment in cash with 20.00% for 2022 (Record date)
- 03/22/2023 DBD Dividend payment in cash with 20.00% for 2022
- 07/29/2022 DBD Annoucement of the change of listing - 17,271,115 shares
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
